cagrilintide vs retatrutide vs tirzepatide retatrutide: amylin analogue triple agonist compared Retatrutide Vs Cagrilintide | Triple

Mounjaro introduces a new class of glucose-lowering agents that go beyond traditional monotherapy, offering robust clinical outcomes for patients with type 2 diabetes

Peptides may be considered as part of a broader treatment approach that includes nutrition, physical activity, and medical evaluation

Why should we reconsider how these drugs are prescribed

Common side effects include: nausea vomiting diarrhoea constipation abdominal discomfort bloating reduced appetite acid reflux Most symptoms occur: during dose escalation within the first few weeks after dose increases They are usually mild to moderate and often improve as the body adapts, particularly when doses are increased gradually under clinical supervision

Their comprehensive approach includes behavioral coaching that addresses emotional eating, stress management, and other psychological factors that often sabotage weight management efforts